Drug Database
Back to search

Belgium· BE-AMP-SAM317597-00

Thalidomide BMS 50 mg

A thalidomide product containing thalidomide, registered in Belgium by Bristol-Myers Squibb Pharma. The same ATC class is registered in 15 of our 19 countries.

ATC L04AX02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedThalidomide BMS 50 mgATCL04AX02REGISTER NO.BE-AMP-SAM317597-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about thalidomideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Thalidomide is registered in 15 of 19 countries.

Countries holding a registration under ATC L04AX02 (thalidomide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose
Search thalidomide products by name

Thalidomide · ATC L04AX02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Thalidomide
Manufacturer
Bristol-Myers Squibb Pharma
Country
Belgium (BE)
ATC code
L04AX02
ATC class
Thalidomide
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    7714926
  • be_apb
    2489946
    EUR 419.22

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

902 interactions on record for thalidomide.

Graded by severity as the source publishes them — 176 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check thalidomide against other medicinesHow interaction checks work

Thalidomide · interactions on record

902 records

  • 176 severe
  • 583 moderate
  • 143 info

Most severe, free to view

  • PapaverineA03AD01severe
  • PrednisoloneA07EA01severe
  • HydrocortisoneA07EA02severe
  • PrednisoneA07EA03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Thalidomide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All thalidomide products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Cyprus · Thalidomide Accord
  • Germany · Thalidomid Zentiva
  • Denmark · Thalidomid Accord, Thalidomide Zentiva
  • Spain · Taliodmida Accord
  • France · Thalidomide Accord, Thalidomide Koanaa
  • United Kingdom (Northern Ireland) · Thalidomide Accord-Uk, Thalidomide Eugia (Uk)
  • Hungary · Thalidomide Accord
  • Iceland · Thalidomide Bms
  • Italy · Talidomide Accord, Talidomide Aurobindo
  • Liechtenstein · Thalidomide Bms
  • Malta · Thalidomide Accord
  • Netherlands · Thalidomide, Thalidomide Milstein
  • Norway · Thalidomide Bms, Thalidomide Zentiva
  • Portugal · Talidomida Accord, Talidomida Generis
  • Romania · Talidomidă Accord
  • Sweden · Thalidomide Zentiva
  • Slovenia · Talidomid Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9e0205d-42d4-460b-8651-69253a90a3c6
GET /v1/drugs/d9e0205d-42d4-460b-8651-69253a90a3c6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Thalidomide BMS 50 mg",
  "name_fr": "Thalidomide BMS 50 mg",
  "name_nl": "Thalidomide BMS 50 mg",
  "amp_code": "SAM317597-00",
  "strengths": [
    "50.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Thalidomide",
    "Propylene Glycol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Thalidomide",
  "authorisation_numbers": [
    "EU/1/08/443/001"
  ]
}
API referenceMCP serverPlans

See everything about thalidomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console